Syra Health Corp. Class A... (SYRA)
NASDAQ: SYRA
· Real-Time Price · USD
0.08
-0.02 (-20.00%)
At close: Jun 09, 2025, 3:58 PM
Syra Health Class A Common Stock Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Revenue | 1.86M | 2.01M | 2.25M | 1.97M | 1.75M | 1.77M | 1.58M | 979.25K | 1.19M | 1.97M | 1.51M | 1.19M | 945.35K |
Cost of Revenue | 1.27M | 1.55M | 1.59M | 2.48M | 1.57M | 1.18M | 1.03M | 851.09K | 1.04M | 1.68M | 1.11M | 1.43M | 924.1K |
Gross Profit | 589.16K | 455.37K | 668.3K | -514.43K | 179.29K | 582.04K | 554.54K | 128.16K | 147.16K | 284.43K | 408.94K | -234.99K | 21.25K |
Operating Income | -473.33K | -501.67K | -428.91K | -1.39M | -1.44M | -986.15K | -343.02K | -783.95K | -774.48K | -600.75K | -346.79K | -621.87K | -520.28K |
Interest Income | 4.3K | 2.8K | 13.64K | 3.83K | 981.00 | 116.00 | 2.82K | 4.00 | 2.00 | 11.88K | 7.74K | 19.00 | n/a |
Pretax Income | -472.26K | -504.4K | -417.54K | -1.39M | -1.45M | -995.27K | -354.38K | -802.8K | -785.89K | -612.63K | -354.54K | -627.41K | -523.59K |
Net Income | -472.26K | -504.4K | -417.54K | -1.39M | -1.45M | -995.27K | -354.38K | -802.8K | -785.89K | -612.63K | -354.54K | -627.41K | -523.59K |
Selling & General & Admin | 287.29K | 954.88K | 288.31K | 598.03K | 1.3M | 1.32M | 885.2K | 899.82K | 895.9K | 875.13K | 751.85K | 386.88K | 541.54K |
Research & Development | 37.17K | -5.12K | 34.82K | 277.89K | 277.55K | 240.05K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 738.03K | 7.28K | 774.08K | 17.37K | n/a | n/a | 663.47K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.06M | 957.04K | 1.1M | 875.92K | 1.59M | 1.57M | 897.56K | 912.11K | 907.66K | 885.18K | 755.73K | 386.88K | 541.54K |
Interest Expense | -3.23K | 5.53K | 2.27K | 3.73K | 4.08K | 9.24K | 14.18K | 18.85K | 11.42K | 11.89K | 7.78K | 5.56K | 3.31K |
Selling & Marketing Expenses | n/a | n/a | 134.5K | 13.89K | 15.38K | -869 | n/a | 885.00 | 869.00 | 702.52K | 597.39K | n/a | n/a |
Cost & Expenses | 2.33M | 2.51M | 2.68M | 3.36M | 3.16M | 2.75M | 1.92M | 1.76M | 1.95M | 2.57M | 1.86M | 1.81M | 1.47M |
Income Tax Expense | n/a | n/a | n/a | -4 | 4.08K | 116.00 | 2.82K | 4.00 | 11.42K | n/a | n/a | 4.00 | 5.00 |
Shares Outstanding (Basic) | 11.59M | 7.26M | 7.26M | 6.6M | 6.5M | 6.42M | 4.36M | 5.86M | 4.35M | 5.15M | 4.11M | 5.98M | 5.98M |
Shares Outstanding (Diluted) | 11.59M | 7.26M | 7.26M | 6.6M | 6.5M | 6.42M | 4.36M | 5.86M | 7.28M | 5.15M | 4.11M | 5.98M | 5.98M |
EPS (Basic) | -0.04 | -0.07 | -0.06 | -0.21 | -0.22 | -0.15 | -0.08 | -0.14 | -0.18 | -0.12 | -0.09 | -0.1 | -0.09 |
EPS (Diluted) | -0.04 | -0.07 | -0.06 | -0.21 | -0.22 | -0.15 | -0.08 | -0.14 | -0.11 | -0.12 | -0.09 | -0.1 | -0.09 |
EBITDA | -473.33K | -491.59K | -389.73K | -1.37M | -1.43M | -973.68K | -327.84K | -771.66K | -762.71K | -597.04K | -342.88K | -621.26K | -519.97K |
EBIT | n/a | -498.87K | -415.27K | -1.39M | -1.44M | -986.04K | -340.2K | -783.95K | -774.47K | -600.74K | -346.76K | -621.85K | -520.28K |
Depreciation & Amortization | n/a | 7.28K | 25.54K | 17.37K | 12.54K | 12.36K | 12.36K | 12.29K | 11.76K | 3.71K | 3.88K | 596.00 | 315.00 |